These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Drug hypersensitivity reactions: pathomechanism and clinical symptoms. Pichler WJ; Adam J; Daubner B; Gentinetta T; Keller M; Yerly D Med Clin North Am; 2010 Jul; 94(4):645-64, xv. PubMed ID: 20609855 [TBL] [Abstract][Full Text] [Related]
8. Predicting drug hypersensitivity by in vitro tests. Pichler WJ ALTEX; 2007; 24 Spec No():49-52. PubMed ID: 19835057 [TBL] [Abstract][Full Text] [Related]
9. Delayed drug hypersensitivity: models of T-cell stimulation. Adam J; Pichler WJ; Yerly D Br J Clin Pharmacol; 2011 May; 71(5):701-7. PubMed ID: 21480949 [TBL] [Abstract][Full Text] [Related]
10. Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune Receptors. Pichler WJ; Adam J; Watkins S; Wuillemin N; Yun J; Yerly D Int Arch Allergy Immunol; 2015; 168(1):13-24. PubMed ID: 26524432 [TBL] [Abstract][Full Text] [Related]
11. Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds. Schmid DA; Depta JP; Lüthi M; Pichler WJ Mol Pharmacol; 2006 Jul; 70(1):356-65. PubMed ID: 16617162 [TBL] [Abstract][Full Text] [Related]
12. Cellular mechanisms of T cell mediated drug hypersensitivity. Gerber BO; Pichler WJ Curr Opin Immunol; 2004 Dec; 16(6):732-7. PubMed ID: 15511665 [TBL] [Abstract][Full Text] [Related]
13. Immune mechanism of drug hypersensitivity. Pichler WJ Immunol Allergy Clin North Am; 2004 Aug; 24(3):373-97, v-vi. PubMed ID: 15242717 [TBL] [Abstract][Full Text] [Related]
14. Deciphering the immune pathomechanism of cutaneous drug reactions. Pichler WJ Allergy; 2002; 57 Suppl 72():34-6. PubMed ID: 12144552 [TBL] [Abstract][Full Text] [Related]
15. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. Schnyder B; Mauri-Hellweg D; Zanni M; Bettens F; Pichler WJ J Clin Invest; 1997 Jul; 100(1):136-41. PubMed ID: 9202065 [TBL] [Abstract][Full Text] [Related]
16. HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes. Zanni MP; von Greyerz S; Schnyder B; Brander KA; Frutig K; Hari Y; Valitutti S; Pichler WJ J Clin Invest; 1998 Oct; 102(8):1591-8. PubMed ID: 9788973 [TBL] [Abstract][Full Text] [Related]
17. Stimulation of human T cells with sulfonamides and sulfonamide metabolites. Castrejon JL; Berry N; El-Ghaiesh S; Gerber B; Pichler WJ; Park BK; Naisbitt DJ J Allergy Clin Immunol; 2010 Feb; 125(2):411-418.e4. PubMed ID: 20159253 [TBL] [Abstract][Full Text] [Related]
18. T cell receptor (TCR) interaction with haptens: metal ions as non-classical haptens. Thierse HJ; Gamerdinger K; Junkes C; Guerreiro N; Weltzien HU Toxicology; 2005 Apr; 209(2):101-7. PubMed ID: 15767020 [TBL] [Abstract][Full Text] [Related]
19. Molecular aspects of drug recognition by specific T cells. Britschgi M; von Greyerz S; Burkhart C; Pichler WJ Curr Drug Targets; 2003 Jan; 4(1):1-11. PubMed ID: 12528985 [TBL] [Abstract][Full Text] [Related]